miR-29c contribute to glioma cells temozolomide sensitivity by targeting O6-methylguanine-DNA methyltransferases indirectely.

Xiao, Songhua; Yang, Zhen; Qiu, Xingsheng; Lv, Ruiyan; Liu, Jun; Wu, Ming; Liao, Yiwei; Liu, Qing

Xiao, Songhua; Yang, Zhen; Qiu, Xingsheng; Lv, Ruiyan; Liu, Jun; Wu, Ming; Liao, Yiwei; Liu, Qing.

Affiliation

Xiao S; Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guanzhou, Guangdong, China.
Yang Z; Department of Hypertension and Vascular Disease, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Qiu X; Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Lv R; Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guanzhou, Guangdong, China.
Liu J; Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guanzhou, Guangdong, China.
Wu M; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liao Y; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liu Q; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Oncotarget ; 7(31): 50229-50238, 2016 Aug 02.

Article de En | MEDLINE | ID: mdl-27384876

Sujet(s)
Mots clés

MGMT; TMZ; chemoresistance; glioblastoma; miR-29c

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Résistance aux médicaments antinéoplasiques / O(6)-methylguanine-DNA methyltransferase / Dacarbazine / MicroARN / Gliome Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Animals / Humans Langue: En Journal: Oncotarget Année: 2016 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google